Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.
Caitlyn Tompkins, PharmD
Advertisement
Articles by Caitlyn Tompkins, PharmD
Advertisement
Latest Updated Articles
CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory LymphomasPublished: December 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
2
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
3
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
4
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
5
